FOXO4 has also been identified by a genome-wide RNAi screen to be a suppressor of metastasis through antagonising PI3K/AKT signal pathway and RUNX2-dependent transcription in prostate cancer [53]. Here, AKT1 is linked to prostate carcinoma.